| Rebecca Elaine Turner, PA | |
|
8800 N Tryon St, Charlotte, NC 28262-3300 | |
| (704) 863-6241 | |
| Not Available |
| Full Name | Rebecca Elaine Turner |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 5 Years |
| Location | 8800 N Tryon St, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427680602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 0010-09796 (North Carolina) | Secondary |
| 363A00000X | Physician Assistant | 0010-09796 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atrium Health University City | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Physicians Network Inc | 3375449655 | 1613 |
News Archive
Seattle Genetics, Inc., announced today that it has entered into a collaboration agreement with GlaxoSmithKline (GSK) under which GSK will pay an upfront fee of $12 million for rights to utilize Seattle Genetics' antibody-drug conjugate (ADC) technology with multiple antigens to be named by GSK.
Epigem, a high-tech British micro engineering company, has issued a blood challenge to students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces).
Heart attack, or myocardial infarction, is the number one cause of death worldwide. A study published in the European Heart Journal by scientists at Helmholtz Zentrum München and colleagues from a range of other Bavarian institutions shows that the risk of suffering a heat-induced heart attack has increased significantly in recent years.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Elaine Turner, PA Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Rebecca Elaine Turner, PA 8800 N Tryon St, Charlotte, NC 28262-3300 Ph: (704) 863-6241 |
News Archive
Seattle Genetics, Inc., announced today that it has entered into a collaboration agreement with GlaxoSmithKline (GSK) under which GSK will pay an upfront fee of $12 million for rights to utilize Seattle Genetics' antibody-drug conjugate (ADC) technology with multiple antigens to be named by GSK.
Epigem, a high-tech British micro engineering company, has issued a blood challenge to students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces).
Heart attack, or myocardial infarction, is the number one cause of death worldwide. A study published in the European Heart Journal by scientists at Helmholtz Zentrum München and colleagues from a range of other Bavarian institutions shows that the risk of suffering a heat-induced heart attack has increased significantly in recent years.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise.
› Verified 4 days ago